查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067669

細胞治療監測試劑盒市場規模、佔有率和趨勢分析報告：按產品類型、應用、治療方法、最終用途、地區和細分市場預測（2026-2033 年）

Cell Therapy Monitoring Kits Market Size, Share & Trends Analysis Report By Product (Cell Activation Kit, Stem Cell Kit), By Application (Oncology, Autoimmune Diseases), By Therapy Type, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

細胞治療監測試劑盒市場概述

2025年全球細胞治療監測試劑盒市場規模估計為14億美元，預計2033年將達25億美元。

預計從 2026 年到 2033 年，該市場將以 7.6% 的複合年成長率成長。這一市場成長是由細胞療法的日益普及和對品質監控需求的不斷成長所推動的。

細胞和基因療法的快速發展

細胞和基因療法研發管線的快速擴張是細胞治療監測試劑盒市場的主要驅動力。嵌合體抗原受體T細胞（CAR-T）療法、幹細胞療法和基因編輯療法等先進治療方法正逐步進入臨床和商業化階段。隨著核准療法和臨床試驗的增加，對可靠監測解決方案的需求也日益成長，而研發和生產各階段的多重查核點則有助於試劑盒的持續應用。

此外，細胞療法需要在整個過程中進行嚴格評估，從細胞分離和修飾到增殖和給藥。為了符合監管標準並確保安全性，必須持續監測細胞活力、純度、特性和療效等參數。由於這些療法對製程偏差非常敏感，因此需要對每個批次進行即時監測，這導致檢測頻率增加，專用監測試劑盒也更廣泛應用。

嚴格的監管要求（GMP、FDA、EMA）

嚴格的監管要求是細胞治療監測試劑盒市場的主要驅動力。由於細胞療法是活性且高度可變的產品，美國食品藥物管理局(FDA) 和歐洲藥品管理局 (EMA) 等監管機構對品管、安全性和有效性制定了嚴格的指導方針。製造商必須遵守良好生產規範 (GMP) 和良好實驗室規範 (GLP) 等框架，這些框架要求在研發和生產的每個階段進行全面監測。

要達到這些標準，需要持續評估細胞特性、純度、效力和無菌性等關鍵參數。監測試劑盒在確保批間一致性、可追溯性和法規合規性方面發揮著至關重要的作用，從而降低產品缺陷和不合格的風險。隨著治療方法獲批數量的增加，監管力度也隨之加大，對先進監測解決方案的依賴性不斷增強，推動了市場需求的持續成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：細胞治療監測試劑盒市場：變數、趨勢和範圍

  • 市場譜系展望
  • 市場動態
  • 個案研究的啟示
  • 細胞治療監測套件市場分析工具

第4章：細胞治療監測試劑盒市場：產品具體估算與趨勢分析

  • 全球細胞治療監測試劑盒市場：基於產品的波動分析
  • 全球細胞治療監測試劑盒市場：產品規模及趨勢分析（2021-2033年）
  • 細胞活化試劑盒
  • 免疫細胞分化及增殖試劑盒
  • 幹細胞試劑盒
  • 其他

第5章：細胞治療監測試劑盒市場：按應用分類的估算與趨勢分析

  • 全球細胞治療監測試劑盒市場：基於應用的波動分析
  • 全球細胞治療監測試劑盒市場：按應用領域分類的規模和趨勢分析（2021-2033年）
  • 腫瘤學
  • 自體免疫疾病
  • 心血管疾病
  • 神經病變
  • 肌肉骨骼疾病
  • 其他

第6章：細胞治療監測試劑盒市場：依治療類型分類的估算與趨勢分析

  • 全球細胞治療監測試劑盒市場：按治療類型分類的波動分析
  • 全球細胞治療監測試劑盒市場：按治療類型分類的規模和趨勢分析（2021-2033年）
  • 幹細胞療法
  • 嵌合體抗原受體（CAR）T細胞療法
  • 自然殺手 (NK) 細胞療法
  • 其他

第7章：細胞治療監測試劑盒市場：依最終用途分類的估算與趨勢分析

  • 全球細胞治療監測試劑盒市場：按最終用途分類的波動分析
  • 全球細胞治療監測試劑盒市場：按最終用途分類的規模和趨勢分析（2021-2033年）
  • 醫院和診所
  • 研究機構
  • 生物技術和製藥公司
  • 受託研究機構（CRO）

第8章：細胞治療監測試劑盒市場：區域估算與趨勢分析

  • 2025年及2033年區域市佔率分析
  • 區域市場概覽
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第9章 競爭情勢

  • 公司和競爭對手的分類
  • 策略規劃
  • 2025年公司市場分析
  • 公司簡介列表
    • STEMCELL Technologies Inc.
    • Lonza Group
    • Thermo Fisher Scientific Inc.
    • Merck KGaA（Sigma-Aldrich）
    • BD Biosciences
    • Miltenyi Biotec
    • GE Healthcare
    • Sartorius AG
    • PerkinElmer Inc.
    • Cell Biolabs Inc.
Product Code: GVR-4-68040-908-4

Cell Therapy Monitoring Kits Market Summary

The global cell therapy monitoring kits market size was estimated at USD 1.4 billion in 2025 and is projected to reach USD 2.5 billion by 2033, growing at a CAGR of 7.6% from 2026 to 2033. The market growth is driven by the rising adoption of cell therapies and the increasing need for quality monitoring.

Rapid growth of cell & gene therapies

The rapid expansion of the cell and gene therapy pipeline is a key driver of the cell therapy monitoring kits market. Advanced modalities such as chimeric antigen receptor T-cell (CAR-T) therapy, stem cell therapies, and gene-edited treatments are advancing across clinical and commercial stages. As approvals and clinical trials increase, the demand for reliable monitoring solutions rises, with multiple checkpoints across development and manufacturing driving consistent kit usage.

In addition, cell therapies require strict evaluation throughout processes such as cell isolation, modification, expansion, and infusion. Parameters, including viability, purity, identity, and potency, must be continuously monitored to meet regulatory standards and ensure safety. Due to their sensitivity to process variations, these therapies require real-time, batch-specific monitoring, leading to higher testing frequency and greater adoption of specialized monitoring kits.

Strong Regulatory Requirements (GMP, FDA, EMA)

Stringent regulatory requirements are a major driver of the cell therapy monitoring kits market. As cell therapies are living, highly variable products, regulatory bodies such as the U.S. Food and Drug Administration and the European Medicines Agency enforce strict guidelines for quality control, safety, and efficacy. Manufacturers must comply with frameworks like Good Manufacturing Practice and Good Laboratory Practice, which require comprehensive monitoring at every stage of development and production.

To meet these standards, continuous assessment of critical parameters such as cell identity, purity, potency, and sterility is essential. Monitoring kits play a crucial role in ensuring batch-to-batch consistency, traceability, and regulatory compliance, reducing the risk of product failure or rejection. As regulatory scrutiny intensifies alongside increasing therapy approvals, the reliance on advanced monitoring solutions continues to grow, driving sustained market demand.

Global Cell Therapy Monitoring Kits Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the cell therapy monitoring kits market report based on product, application, therapy type, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Cell Activation Kit
  • Immune Cell Differentiation and Expansion Kits
  • Stem Cell Kit
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Autoimmune Diseases
  • Cardiovascular Diseases
  • Neurological Disorders
  • Musculoskeletal Disorders
  • Others
  • Therapy Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Stem Cell Therapies
  • Chimeric Antigen Receptor (CAR) T-Cell Therapies
  • Natural Killer (NK) Cell Therapies
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Clinics
  • Research Institutes
  • Biotechnology and Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Application Segment
    • 1.2.3. Therapy Type Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Cell Therapy Monitoring Kits Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rapid growth of cell & gene therapies
      • 3.2.1.2. Strong regulatory requirements (GMP, FDA, EMA)
      • 3.2.1.3. Technological advancements in analytical platforms
      • 3.2.1.4. Growth in biopharmaceutical manufacturing and outsourcing
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of monitoring technologies
      • 3.2.2.2. Complexity of cell therapy manufacturing
      • 3.2.2.3. Limited scalability and workflow integration
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenge analysis
  • 3.3. Case Study Insights
  • 3.4. Cell Therapy Monitoring Kits Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
    • 3.4.2. PESTEL Analysis

Chapter 4. Cell Therapy Monitoring Kits Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Cell Therapy Monitoring Kits Market Product Movement Analysis
  • 4.3. Global Cell Therapy Monitoring Kits Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Cell Activation Kit
    • 4.4.1. Cell Activation Kit market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Immune Cell Differentiation and Expansion Kits
    • 4.5.1. Immune Cell Differentiation and Expansion Kits market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Stem Cell Kit
    • 4.6.1. Stem Cell Kit market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Cell Therapy Monitoring Kits Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Cell Therapy Monitoring Kits Market Application Movement Analysis
  • 5.3. Global Cell Therapy Monitoring Kits Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Autoimmune Diseases
    • 5.5.1. Autoimmune Diseases market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Cardiovascular Diseases
    • 5.6.1. Cardiovascular Diseases market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Neurological Disorders
    • 5.7.1. Neurological Disorders market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8. Musculoskeletal Disorders
    • 5.8.1. Musculoskeletal Disorders market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.9. Others
    • 5.9.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Cell Therapy Monitoring Kits Market: Therapy Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Cell Therapy Monitoring Kits Market Therapy Type Movement Analysis
  • 6.3. Global Cell Therapy Monitoring Kits Market Size & Trend Analysis, by Therapy Type, 2021 to 2033 (USD Million)
  • 6.4. Stem Cell Therapies
    • 6.4.1. Stem Cell Therapies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Chimeric Antigen Receptor (CAR) T-Cell Therapies
    • 6.5.1. Chimeric Antigen Receptor (CAR) T-Cell Therapies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Natural Killer (NK) Cell Therapies
    • 6.6.1. Natural Killer (NK) Cell Therapies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Cell Therapy Monitoring Kits Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Cell Therapy Monitoring Kits Market End Use Movement Analysis
  • 7.3. Global Cell Therapy Monitoring Kits Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Hospitals and Clinics
    • 7.4.1. Hospitals and Clinics market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Research Institutes
    • 7.5.1. Research Institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Biotechnology and Pharmaceutical Companies
    • 7.6.1. Biotechnology and Pharmaceutical Companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Contract Research Organizations (CROs)
    • 7.7.1. Contract Research Organizations (CROs) market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Cell Therapy Monitoring Kits Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033
  • 8.4. North America
    • 8.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Competitive scenario
      • 8.4.4.3. Regulatory framework
      • 8.4.4.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Competitive scenario
      • 8.5.8.3. Regulatory framework
      • 8.5.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.5.9. Denmark
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Competitive scenario
      • 8.5.9.3. Regulatory framework
      • 8.5.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Competitive scenario
      • 8.6.4.3. Regulatory framework
      • 8.6.4.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Competitive scenario
      • 8.6.5.3. Regulatory framework
      • 8.6.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Competitive scenario
      • 8.6.6.3. Regulatory framework
      • 8.6.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Competitive scenario
      • 8.6.7.3. Regulatory framework
      • 8.6.7.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive scenario
      • 8.7.3.3. Regulatory framework
      • 8.7.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Competitive scenario
      • 8.8.2.3. Regulatory framework
      • 8.8.2.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Competitive scenario
      • 8.8.3.3. Regulatory framework
      • 8.8.3.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Competitive scenario
      • 8.8.4.3. Regulatory framework
      • 8.8.4.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Competitive scenario
      • 8.8.5.3. Regulatory framework
      • 8.8.5.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2025
  • 9.4. Company Profiles/Listing
    • 9.4.1. STEMCELL Technologies Inc.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Lonza Group
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Thermo Fisher Scientific Inc.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Merck KGaA (Sigma-Aldrich)
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. BD Biosciences
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Miltenyi Biotec
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. GE Healthcare
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Sartorius AG
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. PerkinElmer Inc.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Cell Biolabs Inc.
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global cell therapy monitoring kits market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 4 Global cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 5 Global cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 6 Global cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 7 North America cell therapy monitoring kits market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 9 North America cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 10 North America cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 11 North America cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 12 U.S. cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 13 U.S. cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 14 U.S. cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 15 U.S. cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Canada cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 17 Canada cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 18 Canada cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 19 Canada cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 20 Mexico cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 21 Mexico cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 22 Mexico cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 23 Mexico cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Europe cell therapy monitoring kits market, by country, 2021 - 2033 (USD Million)
  • Table 25 Europe cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 26 Europe cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 27 Europe cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 28 Europe cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 29 Germany cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 30 Germany cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 31 Germany cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 32 Germany cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 33 UK cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 34 UK cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 35 UK cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 36 UK cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 37 France cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 38 France cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 39 France cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 40 France cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Italy cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 42 Italy cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 43 Italy cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 44 Italy cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Spain cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 46 Spain cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 47 Spain cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 48 Spain cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Denmark cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 50 Denmark cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 51 Denmark cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 52 Denmark cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 53 Sweden cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 54 Sweden cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 55 Sweden cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 56 Sweden cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 57 Norway cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 58 Norway cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 59 Norway cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 60 Norway cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 61 Asia Pacific cell therapy monitoring kits market, by country, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 66 China cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 67 China cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 68 China cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 69 China cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 70 Japan cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 71 Japan cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 72 Japan cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 73 Japan cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 74 India cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 75 India cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 76 India cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 77 India cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 78 South Korea cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 79 South Korea cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 80 South Korea cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 81 South Korea cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Australia cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 83 Australia cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 84 Australia cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 85 Australia cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Thailand cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 87 Thailand cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 88 Thailand cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 89 Thailand cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 90 Latin America cell therapy monitoring kits market, by country, 2021 - 2033 (USD Million)
  • Table 91 Latin America cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 92 Latin America cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 93 Latin America cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 94 Latin America cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 95 Brazil cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 96 Brazil cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 97 Brazil cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 98 Brazil cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 99 Argentina cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 100 Argentina cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 101 Argentina cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 102 Argentina cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 103 MEA cell therapy monitoring kits market, by country, 2021 - 2033 (USD Million)
  • Table 104 MEA cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 105 MEA cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 106 MEA cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 107 MEA cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 108 South Africa cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 109 South Africa cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 110 South Africa cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 111 South Africa cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 112 Saudi Arabia cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 116 UAE cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 117 UAE cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 118 UAE cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 119 UAE cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)
  • Table 120 Kuwait cell therapy monitoring kits market, by product, 2021 - 2033 (USD Million)
  • Table 121 Kuwait cell therapy monitoring kits market, by application, 2021 - 2033 (USD Million)
  • Table 122 Kuwait cell therapy monitoring kits market, by therapy type, 2021 - 2033 (USD Million)
  • Table 123 Kuwait cell therapy monitoring kits market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Cell therapy monitoring kits market: Market outlook
  • Fig. 5 Cell therapy monitoring kits market: Segment outlook
  • Fig. 6 Cell therapy monitoring kits market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Cell therapy monitoring kits market driver impact
  • Fig. 9 Cell therapy monitoring kits market restraint impact
  • Fig. 10 Cell therapy monitoring kits market: Product outlook and key takeaways
  • Fig. 11 Cell therapy monitoring kits market: Product movement analysis
  • Fig. 12 Cell activation kit market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Immune cell differentiation and expansion kits market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Stem cell kit market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Cell therapy monitoring kits market: Application outlook and key takeaways
  • Fig. 17 Cell therapy monitoring kits market: Application movement analysis
  • Fig. 18 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Autoimmune diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Cardiovascular diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Neurological disorders market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Musculoskeletal disorders market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Cell therapy monitoring kits market: Therapy type outlook and key takeaways
  • Fig. 25 Cell therapy monitoring kits market: Therapy type movement analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Stem cell therapies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Chimeric Antigen Receptor (CAR) T-Cell therapies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Natural Killer (NK) Cell therapies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Cell therapy monitoring kits market: End use outlook and key takeaways
  • Fig. 31 Cell therapy monitoring kits market: End use movement analysis market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Hospitals and clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Biotechnology and pharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Contract Research Organizations (CROs)
  • Fig. 36 Global cell therapy monitoring kits market: Regional outlook and key takeaways
  • Fig. 37 Global cell therapy monitoring kits market: Regional movement analysis
  • Fig. 38 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Key country
  • Fig. 42 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)